@article{10913, keywords = {DPP-4 inhibitor, SGLT2 inhibitor, Cohort study, diabetes complications, pharmacoepidemiology, Type 2 diabetes}, author = {V. van Hulten and J. Driessen and J. Starup-Linde and Z. Al-Mashhadi and R. Viggers and O. Klungel and P. Souverein and P. Vestergaard and C. Stehouwer and J. van den Bergh}, title = {The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus}, year = {2023}, journal = {Diabetes Obes Metab}, edition = {2023/07/28}, isbn = {1462-8902}, doi = {10.1111/dom.15220}, note = {1463-1326 van Hulten, Veerle Orcid: 0000-0002-4233-7504 Driessen, Johanna H M Starup-Linde, Jakob K Al-Mashhadi, Zheer K Viggers, Rikke Klungel, Olaf H Souverein, Patrick C Vestergaard, Peter Stehouwer, Coen D A Orcid: 0000-0001-8752-3223 van den Bergh, Joop P Novo Nordisk Steno Collaborative Grant 2018/ Journal Article England Diabetes Obes Metab. 2023 Jul 28. doi: 10.1111/dom.15220.}, language = {eng}, }